Journal of Community Nursing - page 34

34 JCN
2013,Vol 27, No 4
Hermans MH (2007) Silver-containing
dressings and the need for evidence.
Adv Skin Wound Care
20(3):
166–73
Huovinen S, Kotilainen P, Jarvinen H, et
al (1994) Comparison of ciprofloxacin
or trimethoprim therapy for venous
leg ulcers: results of a pilot study.
J Am
Acad Dermatol
31:
279–81
Iheanado I (2010) Silver dressings — do
they work?
Drug Ther Bull
48(4):
38–42
International Consensus (2012)
Appropriate Use of Silver Dressings
in Wounds. An expert working
group consensus.
London: Wounds
International. Available at: www.
woundsinternational.com/clinical-
guidelines/international-consensus-
appropriate-use-of-silver-dressings-in-
wounds (accessed 10 August, 2013)
Kingsley A (2001) A proactive approach
to wound infection.
Nurs Standard
15(30):
50–8
Klasen H (2000a) Historical review of the
use of silver in the treatment of burns.
I. Early uses.
Burns
26(2):
117–30
Klasen H (2000b) A historical review of
the use of silver in the treatment of
burns. II. Renewed interest for silver.
Burns
26(2):
131–38
Lansdown ABG (2002) Silver I: its
antibacterial properties and
mechanism of action.
J Wound Care
11(4):
125–30
Lawrence JC (1998) The use of iodine as
an antiseptic agent.
J Wound Care
7:
421–25
Leaper D, Drake R (2010) Should one size
fit all? An overview and critique of the
VULCAN study on silver dressings.
Int
Wound J
8(1):
1–4
Marr KA, Sexton DJ, Conlon PJ, et al
(1997) Catheter-related bacteremia and
outcome of attempted catheter salvage
in patients undergoing hemodialysis.
Ann Intern Med
127(4):
275–480
McIntosh C (2007) Recognition of
infection in the diabetic foot.
Wound
Essentials
2:
176–78
Mertz PM, Ovington LG (1993) Wound
healing microbiology.
Dermatol Clin
11(4):
739–47
Michaels JA, Campbell WB, King BM, et al
(2009) Randomised controlled trial and
cost-effectiveness analysis of silver-
donating antimicrobial dressings for
venous leg ulcers (VULCAN trial).
Br J
Surg
96(10):
1147–56
Molan PC (2001) Honey as a topical
antibacterial agent for treatment of
infected wounds.
World Wide Wounds
Available at:
(accessed 10 August, 2013)
Molan PC, Betts JA (2004) Clinical usage
of honey as a wound dressing: an
update.
J Wound Care
13(9):
353–56
Moore K, Gray D (2007) Using PHMB
antimicrobial to prevent wound
infection.
Wounds UK
3(2):
96–102
Moss AH, Vasilakis C, Holley JL et al
(1990) Use of a silicone dual lumen
catheter with a Dacron cuff as a long-
term vascular access for hemodialysis
patients.
Am J Kidney Dis
16(3):
211–15
Ousey K, McIntosh C (2009) Topical
antimicrobial agents for the treatment
of chronic wounds.
Br J Comm Nurs
14(9
Suppl):
S6–S15
Parsons D, Bowler PG, Myles V, Jones S
(2005) Silver antimicrobial dressings
in wound management: a comparison
of antibacterial, physical, and chemical
characteristics.
Wounds
17(8):
222–32
Patel S (2010) Investigating wound
infection.
Wound Essentials
5:
40–7
Penhallow K (2005) A review of studies
that examine the impact of infection on
the normal wound-healing process.
J
Wound Care
14(3):
123–26
Pietsch T, Kraft R (2006) Antimikrobielle
Wirksamkeitausgewählter
Substanzenfür die Wasserdesinfektion
in DentaleinheitenmitBiofilmen.
Aseptica
12(4):
3–4
Presterl E, Suchomel M, Eder M, et al
(2007) Effects of alcohols, povidone-
iodine and hydrogen peroxide on
biofilms of
Staphylococcus epidermidis
.
J
Antimicrob Chemother
60(2):
417–20
Rhoads DD, Wolcott RD, Percival SL
(2008) Biofilms in wounds: management
strategies.
J Wound Care
17(11):
502–08
Robson MC (1997) Wound infection: a
failure of wound healing caused by an
imbalance of bacteria.
Surg Clin North
Am
77(3):
637–50
Robson MC, Stenberg BD, Heggars JP
(1990) Wound healing alterations
caused by infection.
Clin Plast Surg
17(3):
485–92
Rumbaugh KP, Griswold JA, Iglewski
BH, Hamood AN (1999) Contribution
of quorum sensing to the virulence of
Pseudomonas aeruginosa
in burn
wound infection.
Infect Immun
67:
5854–62
Schreier H, Erdos G, Reimer K, Konig B,
Konig W, Fleischer W (1997) Molecular
effects of povidone-iodine on relevant
micro-organisms: an electron-
microscopic and biochemical study.
Dermatology
195(Suppl):
111–16
Seipp HM, Hofmann S, Hack A,
Skowronsky A, Hauri A (2005)
Wirksamkeit verschiedener
wundspüllösungengegenüber biofilmen.
J Wound Healing
(ZfW)
4:
160–64
Sibbald RG, Browne AC, Coutts P, Queen
D (2001) Screening evaluation of
ionised nanocrystalline silver dressing
in chronic wound care.
Ostomy Wound
Manage
47:
38–43
Thomas S (2010)
Surgical Dressings
and Wound Management
. Medetec
Publications, Cardiff
Wan AT, Conyers RA, Coombs CJ,
Masterton JP (1991) Determination
of silver in blood, urine and tissues of
volunteers and burn patients.
Clin Chem
37(10):
1683–87
Wang X-Q, Kempf M, Mott J et al (2009)
Silver absorption on burns after the
application of Acticoat: data from
pediatric patients and a porcine burn
model.
J Burn Care Res
30(2):
341–48
Weir D, Scarborough P, Niezgoda JA
(2011) Wound debridement. In: Krasner
DL, Rodeheaver GT, Sibbald RG, eds.
Chronic Wound Care: A Clinical Source
Book for Healthcare Professionals
. 4th
edn. HMP Communications, Malvern
Williams C (2001) Role of CarboFlex in the
nursing management of wound odour.
Br J Nurs
10(2):
122–25
White RJ, Cooper R, Kingsley A (2001)
Wound colonisation and infection: the
role of topical antimicrobials.
Br J Nurs
10(9):
563–78
White R, Cutting K, Ousey K, et al (2010)
Letter to the editor: Randomised
controlled trial and cost effectiveness
analysis of silver donating antimicrobial
dressings for venous leg ulcers
(VULCAN trial) (
Br J Surg
2009;
96:
1147–56).
Br J Surg
97(3):
459–60;
authors’ reply: 460
White R (2011) Wound dressings and
other topical treatment modalities in
bioburden control.
J Wound Care
20(9):
431–39
Wolcott RD, Dowd S, Kennedy J, Jones CE
(2008) Biofilm-based wound care.
Adv
Wound Care
1:
311–16
World Union of Wound Healing Societies
(2008)
Wound Infection in Clinical
Practice: An International Consensus
.
Medical Education Partnership Ltd,
London
Wright JB, Lam K, Burrell RE (1998)
Wound management in an era of
increasing bacterial antibiotic resistance
: a role for topical silver treatment.
Am J
Infect Control
26(6):
572–77
Zaki I, Shall L, Dalziel KL (1994)
Bacitracin: a significant sensitiser in leg
ulcer patients?
Contact Dermatitis
31:
92–94
WOUND CARE
1...,24,25,26,27,28,29,30,31,32,33 35,36,37,38,39,40,41,42,43,44,...116